Zyprexa enjoying strong initial success

Zyprexa, the company's potential breakthrough medication for schizophrenia, is having an ''eye popper'' of a first month on the market. She said that in October, doctors wrote 13,000 prescriptions for Zyprexa, compared with the first month for Johnson & Johnson's (JNJ) Risperdal, which had 5,000 in February 1994. Investigators and investors both eagerly anticipate the results of a head-to-head study of the drugs, to be revealed December 11.

[ Home] [News]